Stay updated on Efficacy & Safety of M2951 in Relapsing MS Clinical Trial
Sign up to get notified when there's something new on the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page.

Latest updates to the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page
- ChecktodayNo Change Detected
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page now includes an explicit note of the 2016 U.S. NIH Grant/Contract funding, and the revision tag has been updated from v3.6.5 to v3.6.6.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe page shows a new revision label (v3.6.5) replacing the previous v3.6.4, indicating an update to the site’s revision history rather than changes to trial content.SummaryDifference0.0%

- Check42 days agoChange DetectedThe location entries for Zaporizhzhia in Ukraine have been updated to Zaporizhzhya with postal codes 69035 and 69600, adding two entries and removing the previous Zaporizhzhia spellings for those codes to reflect a standardized city name.SummaryDifference0.1%

- Check50 days agoChange DetectedThe page shows a revision tag update from v3.6.3 to v3.6.4, indicating a small software update to the site hosting the page.SummaryDifference0.0%

- Check71 days agoChange DetectedA new revision tag v3.6.3 appears, replacing the previous v3.6.2, signaling a minor version update to the page's software. This update does not modify the study content or visible details.SummaryDifference0.0%

- Check78 days agoChange DetectedA newer revision (v3.6.2) has been added, replacing the previous revision (v3.6.0) in the study documents section.SummaryDifference0.0%

Stay in the know with updates to Efficacy & Safety of M2951 in Relapsing MS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy & Safety of M2951 in Relapsing MS Clinical Trial page.